Revolutionary Findings in Breast Cancer Screening
A landmark clinical trial has revolutionized breast cancer screening by demonstrating the remarkable effectiveness of artificial intelligence in mammography. The Mammography Screening with Artificial Intelligence (MASAI) trial, published in…
Strategic Acquisition Enhances AI Capabilities
ScreenPoint Medical’s acquisition of Biomediq A/S on January 8, 2025, represents a milestone in AI-driven breast cancer detection. This strategic merger follows ten years of collaborative research, integrating Biomediq’s quantitative…
What You Should Know:
– ScreenPoint Medical, a provider of AI-powered breast cancer screening solutions, acquires Biomediq A/S, a research-based company specializing in quantitative imaging biomarkers. Financial details of the acquisition were not disclosed.
– ScreenPoint’s…
Continue Reading
In resource-constrained countries like India, mammography-based breast screening is challenging to implement. This state-wide study, funded by the Government of Punjab, evaluated the use of Thermalytix, a low-cost, radiation-free AI tool, for breast cancer…
Continue Reading
Introduction
The Transpara Breast AI system is transforming breast cancer screening by delivering unmatched diagnostic precision and reducing false negatives. Developed with cutting-edge artificial intelligence, Transpara assists radiologists in detecting cancers that might otherwise go…
What You Should Know:
– Lunit, a leading provider of AI-powered cancer diagnostics solutions, has announced a strategic alliance with VIDI Group, the largest private radiology and radiotherapy network in France.
– The partnership will expand…
Continue Reading
Introduction
In a significant step toward enhancing healthcare for military personnel and their families, the Defense Health Agency (DHA) has entered into a groundbreaking partnership with Volpara Health. Known for its cutting-edge breast health technology…
What You Should Know:
– MICA Artificial Intelligence and Baptist Health South Florida have joined forces in a groundbreaking collaboration to transform breast cancer detection.
– By integrating MICA AI’s innovative technology into mammography, the partnership…
Continue Reading
What You Should Know:
– Volpara Health, a global leader in cancer detection software, has been awarded a significant contract with the U.S. Defense Health Agency (DHA) valued at $7.3M over five years.
– The contract…
Continue Reading
What You Should Know:
– Vara, a Berlin, Germany-based provider of AI-enabled breast cancer detection, has announced the successful closure of a $8.9M (€8M EUR) Series B funding round.
– This investment, co-led by Smart Family…
Continue Reading
